XLV allocates 45.2% of its weight to pharmaceuticals names like Johnson & Johnson (NYSE: JNJ) and Pfizer (NYSE: PFE). Making XLV all the more alluring is the health care sector’s reputation for being a buy in the month of October. Over the previous four Octobers, XLV has traded higher three times with 2012 the outlier. [October Opportunity for These Sector ETFs]
Health Care Select Sector SPDR
ETF Trends editorial team contributed to this post.